» Articles » PMID: 21937582

Biology of Cardiac Sodium Channel Nav1.5 Expression

Overview
Journal Cardiovasc Res
Date 2011 Sep 23
PMID 21937582
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Na(v)1.5, the pore forming α-subunit of the voltage-dependent cardiac Na(+) channel, is an integral membrane protein involved in the initiation and conduction of action potentials. Mutations in the gene-encoding Na(v)1.5, SCN5A, have been associated with a variety of arrhythmic disorders, including long QT, Brugada, and sick sinus syndromes as well as progressive cardiac conduction defect and atrial standstill. Moreover, alterations in the Na(v)1.5 expression level and/or sodium current density have been frequently noticed in acquired cardiac disorders, such as heart failure. The molecular mechanisms underlying these alterations are poorly understood, but are considered essential for conception of arrhythmogenesis and the development of therapeutic strategies for prevention or treatment of arrhythmias. The unravelling of such mechanisms requires critical molecular insight into the biology of Na(v)1.5 expression and function. Therefore, the aim of this review is to provide an up-to-date account of molecular determinants of normal Na(v)1.5 expression and function. The parts of the Na(v)1.5 life cycle that are discussed include (i) regulatory aspects of the SCN5A gene and transcript structure, (ii) the nature, molecular determinants, and functional consequences of Na(v)1.5 post-translational modifications, and (iii) the role of Na(v)1.5 interacting proteins in cellular trafficking. The reviewed studies have provided valuable information on how the Na(v)1.5 expression level, localization, and biophysical properties are regulated, but also revealed that our understanding of the underlying mechanisms is still limited.

Citing Articles

Binding of to dystrophin impairs the membrane trafficking of Nav1.5 protein and increases ventricular arrhythmia susceptibility.

Xue G, Yang J, Zhang Y, Yang Y, Zhang R, Li D Elife. 2025; 12.

PMID: 39773412 PMC: 11706603. DOI: 10.7554/eLife.89690.


Isoform-specific N-linked glycosylation of NaV channel α-subunits alters β-subunit binding sites.

Beaudoin C, Kohli M, Salvage S, Liu H, Arundel S, Hamaia S J Gen Physiol. 2024; 157(1).

PMID: 39680039 PMC: 11666101. DOI: 10.1085/jgp.202413609.


Requirement of β subunit for the reduced voltage-gated Na current of a Brugada syndrome patient having novel double missense mutation (p.A385T/R504T) of .

Park N, Choi S, Park S, Woo J, Kim H, Kim W Korean J Physiol Pharmacol. 2024; 28(4):313-322.

PMID: 38926839 PMC: 11211759. DOI: 10.4196/kjpp.2024.28.4.313.


Opioids-Induced Long QT Syndrome: A Challenge to Cardiac Health.

Hu J, Song Y, Huang X, Li C, Jin X, Cen L Cardiovasc Toxicol. 2024; 24(5):472-480.

PMID: 38630336 PMC: 11076354. DOI: 10.1007/s12012-024-09853-6.


Persistent PKA activation redistributes NaV1.5 to the cell surface of adult rat ventricular myocytes.

Bernas T, Seo J, Wilson Z, Tan B, Deschenes I, Carter C J Gen Physiol. 2024; 156(2).

PMID: 38226948 PMC: 10791559. DOI: 10.1085/jgp.202313436.